← Back to Search

Text Messaging + Contingency Management for Opioid Use Disorder

N/A

Recruiting

Led By Kit Delgado, MD, MS

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Participants must be 18 or older

* Screen positive for OUD

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to improve treatment for opioid use disorder by providing ongoing support post-discharge from the Emergency Department. Patients will be randomly assigned to different levels of support, including daily check-ins and contingency management

Who is the study for?

This trial is for adults over 18 with Opioid Use Disorder (OUD) who are being discharged from the Emergency Department with a prescription for Buprenorphine. Participants must be able to read English and have a mobile phone that can receive text messages.

What is being tested?

The study tests if daily text message check-ins and contingency management (a reward system for positive behavior) can help people stay engaged in addiction treatment after leaving the hospital. Patients will be randomly placed into one of four groups to see how these methods work.

What are the potential side effects?

Since this trial involves non-medical interventions like text messaging and behavioral incentives, there are no direct medical side effects. However, participants may experience stress or anxiety related to regular communication about their treatment adherence.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Engagement in any addiction treatment at 30 days of randomization

Secondary study objectives

ED and Hospital Utilization and mortality

Engagement in addition treatment within 14 days

Other study objectives

Comparative analysis across groups

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Active Control

Group I: Augmented Usual care + Contingency Management (CM)Active Control1 Intervention

AUC: Standard Way to Health Care text line. Patients can call or text the on-call substance use navigators (SUN) from 9a-9p, 7 days a week. Participants across all arms will receive an intake survey, and follow-up surveys at day 15, day 30, month 3, and month 6. CM: Patients will also receive incentives for engagement with treatment.

Group II: Augmented usual care + text-message check-ins + contingency managementActive Control2 Interventions

AUC: Standard Way to Health Care text line. Patients can call or text the on-call substance use navigators (SUN) from 9a-9p, 7 days a week. Text check-in: Patients will also receive incentives for engagement with treatment and Participants across all arms will receive an intake survey, and follow-up surveys at day 15, day 30, month 3, and month 6. CM: Patients will also receive incentives for engagement with treatment.

Group III: Augmented Usual Care (AUC)Active Control1 Intervention

Group IV: Augmented usual care + text-message check-insActive Control1 Intervention

0 / 5Eligibility criteria met